1 mg of tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Microdosing Tirzepatide Chart: A Monthly

Download this guide with insights from our Chief Medical Officer to explore: The true driver behind escalating healthcare costs: obesity A history of GLP-1s and how they work Answers to the question - "Should I cover GLP-1s for my employees who want to lose weight?" with insights from +60 client consultation this year A 5-step plan for a holistic, sustainable approach to weight management

Alcohol is absorbed more slowly when gastric emptying is delayed, which means it hits harder and lasts longer than you might expect

GLP-1 pricing would flow through the prescribing clinic or telehealth platform

Currently, there are no FDA approved medications for the treatment of NASH although there are several currently in the pipeline